Provided by Tiger Trade Technology Pte. Ltd.

HealthEquity

95.94
-0.4300-0.45%
Volume:364.10K
Turnover:34.69M
Market Cap:7.94B
PE:34.72
High:96.06
Open:95.55
Low:93.06
Close:96.37
52wk High:107.62
52wk Low:72.76
Shares:82.72M
Float Shares:80.61M
Volume Ratio:0.36
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.76
EPS(LYR):2.46
ROE:11.43%
ROA:6.65%
PB:3.99
PE(LYR):39.00

Loading ...

May 28, 2026

Major Issues Report

Form 8-K - Current report
May 08, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 06, 2026

Major Issues Report

Form 8-K - Current report
Apr 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 17, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Feb 18, 2026

Major Issues Report

Form 8-K - Current report
Jan 30, 2026

Correspondence

Form CORRESP - Correspondence
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities